ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic® technology has been licensed by Ginkgo ...

Dutch privately-held company ProteoNic, a provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic technology has been ...

Study links anxiety to 74% fewer natural killer cells—immune defenders against cancer and infections. Insomnia intensifies ...

Children who grow up in farming communities have long been known to develop far fewer allergies than their urban peers. A new ...

The multi-state infant botulism outbreak related to ByHeart Whole Nutrition infant formula has reached 51 cases, according to ...

A research team that includes Andrew Zydney, Bayard D. Kunkle Chair and professor of chemical engineering at Penn State, and ...

Addressing why only some people develop cancer despite accumulating mutations, Dr Kalluri said, “Cancer is fundamentally a ...

With the final season of The Boys almost upon us, several characters seemed destined to bite the dust. Here's who we think ...

Cervical cancer usually does not cause symptoms until it is advanced. A new guideline makes it easier to detect when ...

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in ...

New research shows that shingles vaccination may not just reduce dementia risk but slow disease progression as well.

The research, published in Nature, shows that older adults in Wales who received the shingles vaccine were about 20% less ...